Celgene has been one of the dominant biotech players in recent history. Its successful R&D and acquisitions have made the company a contender for the industry’s pole position, and its growing commercialization capabilities have effectively utilized its assets to create a diversified growth profile with a 2020 sales CAGR of almost 20%.
Celgene
Celgene Corporation – Diversifying Bets in Research & Development to Ensure Success in the Biopharmaceutical Industry
By investing in in-house drug research and development, partnering with world class research institutes, and acquiring high potential compounds, Celgene has achieved massive success so far and is positioned to continue to do so.